Loading clinical trials...
Loading clinical trials...
An Open-label, Phase II, Two-stage, Study of Bisantrene(Xantrene) in Combination With Fludarabine and Clofarabine as Salvage Therapy for Adult Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)
Conditions
Interventions
Bisantrene
Fludarabine
+1 more
Locations
1
Israel
Chaim Sheba Medical Center
Ramat Gan, Israel
Start Date
August 2, 2021
Primary Completion Date
December 1, 2024
Completion Date
December 1, 2025
Last Updated
November 28, 2023
NCT02098967
NCT01677780
Lead Sponsor
Sheba Medical Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions